Genscript Biotech Corporation (HKG:1548)
Hong Kong · Delayed Price · Currency is HKD 12.36
+0.51 (4.30%)
Apr 2, 2026, 4:08 PM HKT
Genscript Biotech Market Cap
Genscript Biotech has a market cap or net worth of 27.03 billion as of April 2, 2026. Its market cap has decreased by -1.68% in one year.
Market Cap
27.03B
Enterprise Value
23.43B
Revenue
7.47B
Ranking
n/a
PE Ratio
n/a
Stock Price
12.36
Market Cap Chart
Since December 30, 2015, Genscript Biotech's market cap has increased from 2.11B to 27.03B, an increase of 1,179.61%. That is a compound annual growth rate of 28.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 27.03B | -0.48% |
| Dec 31, 2025 | 27.15B | 28.72% |
| Dec 31, 2024 | 21.10B | -49.96% |
| Dec 29, 2023 | 42.16B | -19.78% |
| Dec 30, 2022 | 52.56B | -27.50% |
| Dec 31, 2021 | 72.50B | 229.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Biocytogen Pharmaceuticals (Beijing) | 45.98B |
| Shanghai Henlius Biotech | 41.63B |
| Shanghai Junshi Biosciences | 40.75B |
| InnoCare Pharma | 31.30B |
| Duality Biotherapeutics | 29.17B |
| TransThera Sciences (Nanjing) | 27.97B |
| Keymed Biosciences | 21.02B |
| Ascentage Pharma Group International | 19.16B |